Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trial.

Autor: Lamers-Karnebeek FBG; Radboud Institute for Health Sciences, IQ Healthcare, Radboud University Medical Center, Nijmegen., Luime JJ; Department of Rheumatology, Erasmus Medical Center, Rotterdam., Jansen TL; Department of Rheumatology, Viecuri Medical Center, Venlo., van Riel PLCM; Radboud Institute for Health Sciences, IQ Healthcare, Radboud University Medical Center, Nijmegen., Jacobs JWG
Jazyk: angličtina
Zdroj: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2020 May 01; Vol. 59 (5), pp. 1170-1171.
DOI: 10.1093/rheumatology/kez488
Databáze: MEDLINE